Product Information
ENALAPRIL MALEATE 5 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0724 per EA under NDC 00904731061. Its NADAC has been published 42 times since Dec 17, 2025.
FDA first approved this application on Aug 22, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904731061
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ENALAPRIL MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA075479FDA Approved
8/22/2000
TE Code
AB
On Market Since
8/28/2025
Pharmacological Classes
Price Statistics
The NADAC for ENALAPRIL MALEATE 5 MG TABLET has been published 42 times since Dec 17, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0724 per EA |
|---|---|
| All-time high | $0.0790 (Jul 15, 2026) |
| All-time low | $0.0709 (Mar 18, 2026) |
| 52-week high | $0.0790 |
| 52-week low | $0.0709 |
| Median price | $0.0735 |
| Average price | $0.0738 |
| Largest weekly change | -10.1% (Jul 22, 2026) |
| Weeks tracked | 42 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Enalapril maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ENALAPRIL MALEATE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ENALAPRIL MALEATE 5 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0724 per EA (NDC 00904731061), effective Sep 30, 2026.
How has the price of ENALAPRIL MALEATE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ENALAPRIL MALEATE 5 MG TABLET has held within roughly two percent of its current level. It has been tracked across 42 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for ENALAPRIL MALEATE 5 MG TABLET?
Since Dec 17, 2025, the NADAC for ENALAPRIL MALEATE 5 MG TABLET has ranged from a low of $0.0709 (Mar 18, 2026) to a high of $0.0790 (Jul 15, 2026), with a median of $0.0735 per EA.
Are there cheaper alternatives to ENALAPRIL MALEATE 5 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ENALAPRIL MALEATE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ENALAPRIL MALEATE 5 MG TABLET?
ENALAPRIL MALEATE 5 MG TABLET (NDC 00904731061) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.